BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang JX, Wu HS, Wang H, Zhang JH, Wang Y, Zheng QC. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005; 11(28): 4423-4426 [PMID: 16038046 DOI: 10.3748/wjg.v11.i28.4423]
URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4423.htm
Number Citing Articles
1
Julia Lichtnekert, Volker Vielhauer, Daniel Zecher, Onkar P. Kulkarni, Sebastian Clauss, Stephan Segerer, Veit Hornung, Tanya N. Mayadas, Bruce Beutler, Shizuo Akira, Hans-Joachim Anders. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/TrifAmerican Journal of Physiology-Renal Physiology 2009; 296(4): F867 doi: 10.1152/ajprenal.90213.2008
2
Christopher Y. Lu. Seldin and Giebisch's The Kidney2013; : 2985 doi: 10.1016/B978-0-12-381462-3.00088-4
3
John R. Klune, Allan Tsung. Molecular Biology of Liver Ischemia/Reperfusion Injury: Established Mechanisms and Recent AdvancementsSurgical Clinics of North America 2010; 90(4): 665 doi: 10.1016/j.suc.2010.04.003
4
Fatma Emel Kocak, Aysegul Kucuk, Filiz Ozyigit, Murat Tosun, Cengiz Kocak, Ahmet Kocak, Mehmet Fatih Ekici, Faik Yaylak, Osman Genc. Protective effects of simvastatin administered in the experimental hepatic ischemia-reperfusion injury rat modelJournal of Surgical Research 2015; 199(2): 393 doi: 10.1016/j.jss.2015.06.009
5
Pedro Pimentel-Nunes, João Bruno Soares, Roberto Roncon-Albuquerque Jr, Mário Dinis-Ribeiro, Adelino F Leite-Moreira. Toll-like receptors as therapeutic targets in gastrointestinal diseasesExpert Opinion on Therapeutic Targets 2010; 14(4): 347 doi: 10.1517/14728221003642027
6
Florian Jürgen Raimann, Stefan Dröse, Erik Bonke, Lea Schneider, Elisabeth Tybl, Ilka Wittig, Juliana Heidler, Heinrich Heide, Ivana Josipovic, Matthias Leisegang, Ralf Peter Brandes, Jochen Roeper, Kai Zacharowski, Jan Mersmann. TLR2-Dependent Reversible Oxidation of Connexin 43 at Cys260 Modifies Electrical Coupling After Experimental Myocardial Ischemia/ReperfusionJournal of Cardiovascular Translational Research 2019; 12(5): 478 doi: 10.1007/s12265-019-09887-0
7
Wei Wang, Li Sun, Yonghao Deng, Jie Tang. Synergistic effects of antibodies against high‐mobility group box 1 and tumor necrosis factor‐α antibodies on d‐(+)‐galactosamine hydrochloride/lipopolysaccharide‐induced acute liver failureThe FEBS Journal 2013; 280(6): 1409 doi: 10.1111/febs.12132
8
Chao Hu, Shiqiang Shen, Aimin Zhang, Bo Ren, Fusheng Lin. The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in ratsDigestive and Liver Disease 2014; 46(10): 928 doi: 10.1016/j.dld.2014.06.008
9
Fang Hua, Jing Ma, Tuanzhu Ha, Jim L. Kelley, Race L. Kao, John B. Schweitzer, John H. Kalbfleisch, David L. Williams, Chuanfu Li. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in miceBrain Research 2009; 1262: 100 doi: 10.1016/j.brainres.2009.01.018
10
Yao Tong, Zhuang Yu, Renlingzi Zhang, Xibing Ding, Zhixia Chen, Quan Li. WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in miceBMC Pulmonary Medicine 2018; 18(1) doi: 10.1186/s12890-018-0744-z
11
Jan Mersmann, Nguyen Tran, Kathrina Latsch, Katharina Habeck, Franziska Iskandar, René Zimmermann, Kai Zacharowski. Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient miceResuscitation 2012; 83(11): 1404 doi: 10.1016/j.resuscitation.2012.04.001
12
Athanasios Katsargyris, Chris Klonaris, Andreas Alexandrou, Alexander E Giakoustidis, Ioanna Vasileiou, Stamatios Theocharis. Toll like receptors in liver ischemia reperfusion injury: A novel target for therapeutic modulation?Expert Opinion on Therapeutic Targets 2009; 13(4): 427 doi: 10.1517/14728220902794939
13
Jessica Howell, Paul Gow, Peter Angus, Kumar Visvanathan. Role of toll-like receptors in liver transplantationLiver Transplantation 2014; 20(3): 270 doi: 10.1002/lt.23793
14
Andrew J Vardanian, Jerzy W Kupiec-Weglinski. Organ preservation injury and innate immunityCurrent Opinion in Organ Transplantation 2007; 12(2): 135 doi: 10.1097/MOT.0b013e328091c1c2
15
Christopher Y. Lu, Martin Senitko. Seldin and Giebisch's The Kidney2008; : 2577 doi: 10.1016/B978-012088488-9.50093-0
16
Hossein-Ali Arab, Kee Cheung, Peter E. Hickman, Julia M. Potter, Neal I. Walker, Michael S. Roberts. A comparison of hepatic ischemia/hypoxia–reperfusion injury modelsJournal of Pharmacological and Toxicological Methods 2013; 68(3): 349 doi: 10.1016/j.vascn.2013.03.002
17
Serdar Dogan, Mutay Aslan. Hepatic ischemia–reperfusion injury and therapeutic strategies to alleviate cellular damageHepatology Research 2011; 41(2): 103 doi: 10.1111/j.1872-034X.2010.00765.x
18
Chen Lu, Li Liu, Yuling Chen, Tuanzhu Ha, Jim Kelley, John Schweitzer, John H. Kalbfleisch, Race L. Kao, David L. Williams, Chuanfu Li. TLR2 Ligand Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of Phosphoinositide 3-Kinase/Akt SignalingThe Journal of Immunology 2011; 187(3): 1458 doi: 10.4049/jimmunol.1003428
19
Bjoern M. Thobe, Michael Frink, Frank Hildebrand, Martin G. Schwacha, William J. Hubbard, Mashkoor A. Choudhry, Irshad H. Chaudry. The role of MAPK in Kupffer cell toll‐like receptor (TLR) 2‐, TLR4‐, and TLR9‐mediated signaling following trauma‐hemorrhageJournal of Cellular Physiology 2007; 210(3): 667 doi: 10.1002/jcp.20860
20
Yuanting Gu, Heshui Wu, Jianbo Xu, Lin Wang, Yuan Tian, Chunyou Wang. Expression of toll-like receptor 2/4 on alveolar macrophage in the model of total hepatic ischemia/reperfusion injury in miceThe Chinese-German Journal of Clinical Oncology 2006; 5(4): 298 doi: 10.1007/s10330-006-0498-6
21
Brigitte Vollmar, Michael D. Menger. The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and RepairPhysiological Reviews 2009; 89(4): 1269 doi: 10.1152/physrev.00027.2008
22
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Interferon Regulatory Factor Signalings in Cardiometabolic DiseasesHypertension 2015; 66(2): 222 doi: 10.1161/HYPERTENSIONAHA.115.04898
23
F. Arslan, B. Keogh, P. McGuirk, A. E. Parker. TLR2 and TLR4 in Ischemia Reperfusion InjuryMediators of Inflammation 2010; 2010: 1 doi: 10.1155/2010/704202
24
Wei Ma, Zuo-Ren Wang, Lei Shi, Yue Yuan. Expression of macrophage inflammatory protein-1α in Kupffer cells following liver ischemia or reperfusion injury in ratsWorld Journal of Gastroenterology 2006; 12(24): 3854-3858 doi: 10.3748/wjg.v12.i24.3854
25
Hossein Ali Arab, Farhang Sasani, Mohammad Hossein Rafiee, Ahmad Fatemi, Abbas Javaheri. Histological and biochemical alterations in early-stage lobar ischemia-reperfusion in rat liverWorld Journal of Gastroenterology 2009; 15(16): 1951-1957 doi: 10.3748/wjg.15.1951
26
Moustafa O. Aboelez, Hend A. A. Ezelarab, Ghallab Alotaibi, Deiaa E. Elsayed Abouzed. Inflammatory setting, therapeutic strategies targeting some pro-inflammatory cytokines and pathways in mitigating ischemia/reperfusion-induced hepatic injury: a comprehensive reviewNaunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(9): 6299 doi: 10.1007/s00210-024-03074-y
27
Safak Kiziltas. Toll-like receptors in pathophysiology of liver diseasesWorld Journal of Hepatology 2016; 8(32): 1354-1369 doi: 10.4254/wjh.v8.i32.1354
28
Ioanna Vasileiou, Georgia Kostopanagiotou, Athanasios Katsargyris, Chris Klonaris, Despina Perrea, Stamatios Theocharis. Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia–reperfusion injury?Expert Opinion on Therapeutic Targets 2010; 14(8): 839 doi: 10.1517/14728222.2010.500286
29
Nari Yun, Jung-Woo Kang, Sun-Mee Lee. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory propertiesThe Journal of Nutritional Biochemistry 2012; 23(10): 1249 doi: 10.1016/j.jnutbio.2011.06.018
30
Ana Rosa Rincón Sánchez, Ana Maria Rivas‐Estilla. Role of probiotics in hepatic ischemia‐reperfusion injuryJournal of Gastroenterology and Hepatology 2006; 21(4): 629 doi: 10.1111/j.1440-1746.2006.04334.x
31
Yu Guan, Weifeng Yao, Ke Yi, Chunxiong Zheng, Shixian Lv, Yu Tao, Ziqing Hei, Mingqiang Li. Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion InjurySmall 2021; 17(23) doi: 10.1002/smll.202007727
32
Alexander Georg Khandoga, Andrej Khandoga, Hans-Joachim Anders, Fritz Krombach. POSTISCHEMIC VASCULAR PERMEABILITY REQUIRES BOTH TLR-2 AND TLR-4, BUT ONLY TLR-2 MEDIATES THE TRANSENDOTHELIAL MIGRATION OF LEUKOCYTESShock 2009; 31(6): 593 doi: 10.1097/SHK.0b013e318193c859
33
Christopher Y Lu, John Hartono, Martin Senitko, Jianlin Chen. The inflammatory response to ischemic acute kidney injury: a result of the ‘right stuff’ in the ‘wrong place’?Current Opinion in Nephrology and Hypertension 2007; 16(2): 83 doi: 10.1097/MNH.0b013e3280403c4e